Abstract
Oxidative stress is a key modulator, which modifies the ligand-receptor interactions extracellularly and intracellularly, and influences gene expression. Free radicals can act as secondary messengers in several transduction pathways, and take part in the activation of chemotactic cytokines and surface adhesion molecules etc. Oxidative stress can induce stress response genes, and moderate oxidative stress by down regulating the gene expression of several genes. DNA synthesis, selective gene expression, enzyme activation and modification of cell proliferation are involved in redoxy signal mechanisms. Moderate free radical production can modify the function of kinases or directly activate the transcription factors, thereby also influencing the gene regulation in the nucleus. The “antioxidant” concept has meaning only in defense against free radicals for a long period. Its importance is not doubtful in the therapy of diseases in which free radicals are also involved. “Janus face” antioxidants can stop protein phophorilation and the inhibition of activation of transcription factors. They can also therefore stop cell proliferation and injure the adaptation mechanisms against oxidative stress. The direct roles of these antioxidants in original forms are doubtful in transduction therapy.
Keywords: Redox homeostasis, signal transduction, free radicals, natural antioxidants
Current Signal Transduction Therapy
Title: Redox Homeostasis, Bioactive Agents and Transduction Therapy
Volume: 2 Issue: 3
Author(s): Anna Blazovics
Affiliation:
Keywords: Redox homeostasis, signal transduction, free radicals, natural antioxidants
Abstract: Oxidative stress is a key modulator, which modifies the ligand-receptor interactions extracellularly and intracellularly, and influences gene expression. Free radicals can act as secondary messengers in several transduction pathways, and take part in the activation of chemotactic cytokines and surface adhesion molecules etc. Oxidative stress can induce stress response genes, and moderate oxidative stress by down regulating the gene expression of several genes. DNA synthesis, selective gene expression, enzyme activation and modification of cell proliferation are involved in redoxy signal mechanisms. Moderate free radical production can modify the function of kinases or directly activate the transcription factors, thereby also influencing the gene regulation in the nucleus. The “antioxidant” concept has meaning only in defense against free radicals for a long period. Its importance is not doubtful in the therapy of diseases in which free radicals are also involved. “Janus face” antioxidants can stop protein phophorilation and the inhibition of activation of transcription factors. They can also therefore stop cell proliferation and injure the adaptation mechanisms against oxidative stress. The direct roles of these antioxidants in original forms are doubtful in transduction therapy.
Export Options
About this article
Cite this article as:
Blazovics Anna, Redox Homeostasis, Bioactive Agents and Transduction Therapy, Current Signal Transduction Therapy 2007; 2 (3) . https://dx.doi.org/10.2174/157436207781745364
DOI https://dx.doi.org/10.2174/157436207781745364 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Antiplatelet Treatment in Stroke: New Insights
Current Pharmaceutical Design Mitochondrial Dynamics: An Emerging Paradigm in Ischemia-Reperfusion Injury
Current Pharmaceutical Design The Effects of Antihypertensive Therapy on Haemostatic Parameters
Current Pharmaceutical Design Editorial [Hot Topic: Oxidative Stress Induced-Metabolic Imbalance, Mitochondrial Failure, And Cellular Hypoperfusion As Primary Pathogenetic Factors For The Development Of Alzheimer Disease Which Can Be Used As An Alternate And Successful Drug Treatment Strategy: Past, Present And Future (Guest Editor: Gjumrakch Aliev)]
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic:Metabolic Therapy: An Important Therapeutic Option for the Treatment of Cardiovascular Diseases (Executive Editors: G.M.C. Rosano and G. Barbaro)]
Current Pharmaceutical Design Unmasking Sex-Based Disparity in Neuronal Metabolism
Current Pharmaceutical Design Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension
Current Vascular Pharmacology Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment
Current Pharmaceutical Design How to Investigate the Vascular Changes in Resistant Hypertension
Current Hypertension Reviews Vitamin D Supplementation and Cancer: Review of Randomized Controlled Trials
Anti-Cancer Agents in Medicinal Chemistry Peptide Receptor Radionuclide Therapy with Somatostatin Analogues in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Radiolabelled Quinoline Derivaties for the PET Imaging of Peripheral Benzodiazepine Receptor
Current Medical Imaging From CHD Susceptibility Genes to New Therapeutics
Current Pharmacogenomics Ximelagatran - A Promising New Drug in Thromboembolic Disorders
Current Pharmaceutical Design The Emerging Role of Aromatase Inhibitors in the Adjuvant Management of Breast Cancer
Reviews on Recent Clinical Trials Towards a Better Understanding of Cardiac and Vascular Disease in Patients with Chronic Kidney Disease
Current Cardiology Reviews Advanced In Silico Approaches for Drug Discovery: Mining Information from Multiple Biological and Chemical Data Through mtk- QSBER and pt-QSPR Strategies
Current Medicinal Chemistry Targeting Inflammation in Primary Cardiovascular Prevention
Current Pharmaceutical Design The Coronary Circulation in Cyanotic Congenital Heart Disease
Current Cardiology Reviews